Evidence strongly supports the view that limitations in pancreatic beta-cell lifespan, mass, and function directly contribute to the onset and progression of diabetes.
The retrieved papers consistently demonstrate that beta-cell loss, apoptosis, senescence, and functional decline are central to the pathogenesis of both type 1 and type 2 diabetes. Thus, the claim is supported by current literature focusing on beta-cell dynamics and diabetes onset.